Vise Technologies’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$148K Buy
+17,421
New +$116K ﹤0.01% 1721
2025
Q4
Sell
-23,983
Closed -$185K 1524
2025
Q3
$185K Sell
23,983
-3,669
-13% -$28.6K 0.01% 1143
2025
Q2
$241K Buy
+27,652
New +$200K 0.01% 928
2024
Q4
$274K Buy
30,179
+1,405
+5% +$13.6K 0.02% 630
2024
Q3
$264K Sell
28,774
-920
-3% -$7.61K 0.03% 492
2024
Q2
$290K Buy
29,694
+1,402
+5% +$17.1K 0.05% 318
2024
Q1
$427K Sell
28,292
-2,377
-8% -$43.1K 0.08% 230
2023
Q4
$661K Buy
30,669
+15,379
+101% +$284K 0.14% 150
2023
Q3
$284K Sell
15,290
-862
-5% -$20.1K 0.07% 252
2023
Q2
$409K Buy
+16,152
New +$407K 0.1% 201

Other funds holding TDOC

Vise Technologies's TDOC Position: Q2 2026 in Review

Vise Technologies opened a new position in Teladoc Health (TDOC) in Q2 2026: 17,421 shares worth $148K. The stake represents ﹤0.01% of the portfolio and ranks #1721 among its holdings. This is a return to the name: Vise Technologies previously reported a position in TDOC as recently as Q3 2025.

Vise Technologies first reported a position in TDOC in Q2 2023 and has held it in 10 quarters since. The position peaked at $661K in Q4 2023. 347 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.

  • Vise Technologies held 17,421 shares of Teladoc Health worth $148K as of Q2 2026.
  • Teladoc Health was a new Vise Technologies position in Q2 2026.
  • Teladoc Health made up ﹤0.01% of Vise Technologies's portfolio in Q2 2026, its #1721 holding.
  • Vise Technologies first reported a position in Teladoc Health in Q2 2023 and has held it in 10 quarters since.
  • Vise Technologies's Teladoc Health position peaked at $661K in Q4 2023.
  • 347 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.

Based on Vise Technologies's 13F filing for Q2 2026, filed 11 Aug 2026.